Mary Sobieski
Texas A&M Health Science Center(US)AI Biosciences (United States)(US)High Throughput Biology (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, PARP inhibition in cancer therapy, Glioma Diagnosis and Treatment, Cancer Cells and Metastasis, Cancer Research and Treatments
Most-Cited Works
- → GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer(2019)165 cited
- → Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy(2015)162 cited
- → A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer(2014)44 cited
- → Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer(2021)37 cited
- → Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma(2017)31 cited
- → Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas(2022)26 cited